A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)
Clinical trial NCT04417894 · COMPLETED
Trial details
- NCT number
- NCT04417894
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-08-31
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.